Physician profile
Michael Huther
NPI 1316632136
$4,395.96
in general payments reported to CMS, 2019-2025
14 companies · $2,787 in 2025
The $2,787 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $482 · 2024: $1,126 · 2025: $2,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,617 · Travel and Lodging: $1,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,616.90 |
| Travel and Lodging | $1,779.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $919.22 | 2024-2025 | Ortholoc 2 Lapifuse, Salvation, Citrefix |
| Mid-Atlantic Surgical Systems, LLC | $835.91 | 2023-2025 | |
| Smith+Nephew, INC. | $589.72 | 2023-2025 | Stravix Pl, Versajet, Grafix |
| Arthrex, INC. | $556.40 | 2025 | |
| Integra Lifesciences Corporation | $529.92 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $218.99 | 2025 | Novosorb Btm |
| Linvatec Corporation | $158.80 | 2024-2025 | Biobrace 23mm, Quantum, Hercules |
| Kerecis Limited | $122.81 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lifenet Health | $120.59 | 2023 | |
| Organogenesis INC. | $117.66 | 2024 | |
| Horizon Therapeutics Plc | $112.45 | 2023 | Krystexxa |
| Orthofix Medical, INC. | $56.62 | 2023 | Galaxy Fixation System, Truelok System |
| Exactech, INC. | $36.52 | 2025 | |
| Crossroads Orthopedics, LLC | $20.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Huther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.